# Marketing Campaign Analysis Plan
## Causal Impact Assessment & Investment Recommendations

**Prepared for:** Marketing Director  
**Date:** 2024  
**Objective:** Measure the causal impact of Q2-Q3 2024 marketing campaigns and provide data-driven recommendations for next quarter's investment decisions

---

## Executive Summary

We analyzed four marketing campaigns using appropriate causal inference methods based on each campaign's design. Our key findings:

| Campaign | Method | Estimated Effect | Confidence | Recommendation |
|----------|--------|-----------------|------------|----------------|
| **C001: Spring Email Blast** | A/B Test | **+$4.44/user** | ✅ High | **SCALE UP** |
| **C002: Premium Upsell Push** | Targeted (Biased) | ~$9.85/user | ⚠️ Low | **RE-TEST** with proper design |
| **C003: West Coast Regional** | Difference-in-Differences | **+$3.11/user** | ✅ High | **EXPAND** to other regions |
| **C004: Win-Back Campaign** | A/B Test | **+10.75 pp reactivation** | ✅ High | **CONTINUE** |

**Bottom Line:** Campaigns C001, C003, and C004 show clear, statistically significant positive effects. C002 shows promise but needs proper randomized testing to confirm true causal impact.

---

## Campaign-by-Campaign Analysis

### Campaign C001: Spring Email Blast

#### 1. Data Type & Design
- **Type:** Experimental (Randomized Controlled Trial)
- **Assignment:** Random assignment to 50% of active users
- **Sample Size:** 710 users (359 treatment, 351 control)
- **Outcome:** Monthly spend ($)
- **Period:** April 2024

#### 2. Analytical Method: A/B Test Analysis

**Why this method?**  
Random assignment creates comparable treatment and control groups, allowing us to directly attribute differences in outcomes to the campaign.

**Balance Check:**
- Pre-campaign spending was nearly identical between groups:
  - Treatment: $28.11
  - Control: $28.14
  - Difference: -$0.03 ✅
- This confirms successful randomization

**Results:**
- **Treatment Effect:** +$4.75 per user (pre-to-post change)
- **Control Effect:** +$0.31 per user (natural change)
- **Average Treatment Effect (ATE):** **$4.44 per user**
- **Statistical Significance:** p < 0.0001 (highly significant)

#### 3. Caveats & Limitations
- ✅ **Minimal concerns** - this is the gold standard design
- Assumes no spillover effects between treatment and control users
- Effect measured over one month; long-term impact unknown
- Results apply to "active users" segment only

#### 4. Investment Recommendation
**STRONG RECOMMENDATION TO SCALE UP**
- Clear causal evidence of positive impact
- Cost-effective if email campaign costs < $4.44 per user
- Consider testing variations (subject lines, timing, content) to optimize further

---

### Campaign C002: Premium Upsell Push

#### 1. Data Type & Design
- **Type:** Observational (Targeted campaign with comparison group)
- **Assignment:** Targeted at high-spend users (>$80/month)
- **Sample Size:** 144 users (72 treatment, 72 control)
- **Outcome:** Monthly spend ($)
- **Period:** June 2024

#### 2. Analytical Method: Caution - Selection Bias Present

**Why this is problematic:**  
The treatment and control groups are fundamentally different:
- Treatment group pre-campaign: $200.35
- Control group pre-campaign: $64.77
- **Difference: $135.59** ⚠️

This massive imbalance indicates the groups were NOT randomly assigned. The treatment group consists of much higher spenders, making direct comparison invalid.

**Attempted Adjustments:**
1. **Naive comparison:** $9.76 effect (BIASED - not trustworthy)
2. **Growth-rate adjustment:** $9.85 effect (better, but still assumes parallel trends)

**Why we can't trust these estimates:**
- High spenders may naturally have different spending trajectories
- Regression to the mean could explain changes
- Selection into treatment based on spending creates confounding

#### 3. Caveats & Limitations
- ⚠️ **MAJOR LIMITATION:** Selection bias makes causal inference unreliable
- Cannot determine if the $9.85 effect is real or due to pre-existing differences
- Would need matching, propensity scores, or instrumental variables (not available in current data)
- Best approach: Re-run as proper randomized experiment

#### 4. Investment Recommendation
**RECOMMEND RE-TESTING WITH PROPER RANDOMIZATION**
- The campaign *might* be effective, but we cannot be confident
- **Action Plan:**
  1. Design a proper A/B test within the high-spend segment
  2. Randomly assign 50% to treatment, 50% to control
  3. Ensure balance on pre-campaign spending
  4. Then measure true causal effect
- Do NOT scale based on current evidence alone

---

### Campaign C003: West Coast Regional Push

#### 1. Data Type & Design
- **Type:** Quasi-Experimental (Geographic rollout)
- **Assignment:** All users in West region received campaign; other regions did not
- **Sample Size:** 1,000 users (274 West, 726 Other)
- **Outcome:** Monthly spend ($)
- **Period:** July-August 2024

#### 2. Analytical Method: Difference-in-Differences (DiD)

**Why this method?**  
Geographic rollouts create natural experiments. DiD compares the change in the treatment region to the change in control regions, accounting for time trends that affect all regions.

**DiD Formula:**
```
Effect = (West_Post - West_Pre) - (Other_Post - Other_Pre)
       = ($35.23 - $31.47) - ($28.35 - $27.70)
       = $3.76 - $0.64
       = $3.11
```

**Key Assumption: Parallel Trends**
- Without the campaign, West and Other regions would have followed similar trends
- Pre-campaign difference ($3.77) is acceptable - DiD accounts for level differences
- Both regions showed positive trends, but West increased more

**Results:**
- **West Region Change:** +$3.76
- **Other Regions Change:** +$0.64
- **DiD Estimate:** **+$3.11 per user**
- **Statistical Significance:** p < 0.0001 (highly significant)

#### 3. Caveats & Limitations
- Assumes parallel trends (cannot fully verify with only 2 time periods)
- Regional differences beyond the campaign could affect results
- Spillover effects if West users interact with users in other regions
- Seasonal or regional economic factors could confound results
- Would be stronger with multiple pre-campaign periods to verify parallel trends

#### 4. Investment Recommendation
**RECOMMEND EXPANDING TO OTHER REGIONS**
- Strong evidence of positive causal impact
- Natural next step: Roll out to another region and measure again
- Consider staggered rollout to additional regions for continued learning
- Monitor for diminishing returns in saturated markets

---

### Campaign C004: Win-Back Campaign

#### 1. Data Type & Design
- **Type:** Experimental (Randomized Controlled Trial)
- **Assignment:** Random assignment to 50% of inactive users (60+ days)
- **Sample Size:** 290 users (147 treatment, 143 control)
- **Outcome:** Reactivation (binary: yes/no)
- **Period:** September 2024

#### 2. Analytical Method: A/B Test for Binary Outcomes

**Why this method?**  
Random assignment with binary outcome. We compare reactivation rates between treatment and control groups.

**Balance Check:**
- Both groups had zero activity pre-campaign (by design - targeting inactive users)
- Perfect balance ✅

**Results:**
- **Treatment Reactivation Rate:** 15.65%
- **Control Reactivation Rate:** 4.90%
- **Absolute Lift:** **+10.75 percentage points**
- **Relative Lift:** **+219.6%** (more than 3x the control rate)
- **Statistical Significance:** p = 0.0049 (significant at 1% level)

**Business Impact:**
- Out of 147 treated users, 23 reactivated
- Out of 143 control users, only 7 reactivated
- **Incremental reactivations:** ~16 users
- Value depends on lifetime value of reactivated users

#### 3. Caveats & Limitations
- ✅ **Strong design** - minimal concerns
- Reactivation measured immediately; need to track long-term retention
- Some control users reactivated naturally (4.9%) - campaign accelerated this
- Cost-effectiveness depends on:
  - Cost per email sent
  - Lifetime value of reactivated users
  - Retention rate of reactivated users

#### 4. Investment Recommendation
**STRONG RECOMMENDATION TO CONTINUE**
- Clear, large, statistically significant effect
- Win-back campaigns are typically cost-effective (email is cheap)
- **Action items:**
  1. Track 3-month and 6-month retention of reactivated users
  2. Calculate ROI: (LTV of reactivated users × 16) - campaign costs
  3. Test variations: different messaging, incentives, timing
  4. Consider expanding to users inactive 30-60 days

---

## Cross-Campaign Insights

### What Works
1. **Randomized experiments (C001, C004)** provide the clearest evidence
2. **Email campaigns** show strong performance (C001, C004)
3. **Targeted segments** can be effective, but need proper testing (C002)
4. **Geographic rollouts** (C003) work well when randomization isn't feasible

### What to Avoid
1. **Non-randomized targeting** without proper controls (C002 issue)
2. **Comparing fundamentally different groups** and calling it causal
3. **Scaling campaigns** without statistical validation

### Methodological Lessons
- **Gold Standard:** Randomized A/B tests (C001, C004)
- **Silver Standard:** Quasi-experimental designs like DiD (C003)
- **Problematic:** Targeted campaigns without randomization (C002)

---

## Recommendations for Next Quarter

### Immediate Actions

1. **SCALE:** Spring Email Blast (C001)
   - Proven $4.44 per user effect
   - Low cost, high reach
   - Test monthly cadence

2. **EXPAND:** West Coast Regional Push (C003)
   - Roll out to 1-2 additional regions
   - Use staggered timing for continued DiD analysis
   - Monitor for saturation effects

3. **CONTINUE:** Win-Back Campaign (C004)
   - Maintain monthly cadence for inactive users
   - Track long-term retention metrics
   - Test earlier intervention (30-day inactive)

4. **RE-TEST:** Premium Upsell Push (C002)
   - Design proper randomized experiment
   - Randomly assign within high-spend segment
   - Measure true causal effect before scaling

### Testing Framework for New Campaigns

For any new campaign, follow this decision tree:

```
Can you randomize?
├─ YES → Run A/B test (gold standard)
│         - 50/50 split
│         - Check balance
│         - Measure ATE
│
└─ NO → Is there a natural control group?
    ├─ YES (geographic, temporal) → Use DiD or similar
    │                                - Verify parallel trends
    │                                - Account for confounders
    │
    └─ NO → Use causal inference methods
                - Propensity score matching
                - Regression with controls
                - Instrumental variables
                - BUT: Results less reliable
```

### Budget Allocation Guidance

Based on estimated effects and typical costs:

| Campaign Type | Priority | Suggested Budget % |
|--------------|----------|-------------------|
| Email to active users (C001) | High | 30% |
| Geographic expansion (C003) | High | 25% |
| Win-back campaigns (C004) | High | 20% |
| Premium upsell (C002 retest) | Medium | 15% |
| New experiments | Medium | 10% |

---

## Technical Appendix

### Statistical Methods Used

1. **A/B Test Analysis (C001, C004)**
   - Two-sample t-test for continuous outcomes
   - Chi-square test for binary outcomes
   - Significance level: α = 0.05

2. **Difference-in-Differences (C003)**
   - DiD = (Y_treat,post - Y_treat,pre) - (Y_control,post - Y_control,pre)
   - Assumes parallel trends
   - Robust to time-invariant differences between groups

3. **Selection Bias Assessment (C002)**
   - Balance tests on pre-treatment covariates
   - Growth rate adjustment (sensitivity analysis)
   - Identified as insufficient for causal claims

### Data Quality Notes
- All campaigns have pre/post measurements
- Sample sizes adequate for statistical power
- Missing data minimal
- Outcome metrics clearly defined

### Significance Levels
- *** p < 0.001 (highly significant)
- ** p < 0.01 (very significant)
- * p < 0.05 (significant)
- ⚠️ Biased estimate (not reliable)

---

## Conclusion

We have strong causal evidence that three of four campaigns (C001, C003, C004) generated positive returns. These should be scaled or continued. Campaign C002 requires proper randomized testing before scaling.

The key to successful campaign measurement is **proper experimental design**. When randomization is possible, use it. When not, employ appropriate quasi-experimental methods and clearly communicate limitations.

**Next Steps:**
1. Implement recommendations above
2. Establish standardized A/B testing protocols
3. Build dashboard for ongoing campaign monitoring
4. Schedule quarterly review of campaign performance

---

**Questions or need clarification?** This analysis provides the foundation for evidence-based marketing decisions. All estimates are based on rigorous causal inference methods appropriate to each campaign's design.
